| GALDERMA RESEARCH & DEVELOPMENT, S.N.C. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110027367 | ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS - Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions. | 02-03-2011 |
| 20100284581 | METHOD AND DEVICE FOR ACQUIRING AND PROCESSING DATA FOR DETECTING THE CHANGE OVER TIME OF CHANGING LESIONS - This method for acquiring and processing data for detecting the change over time of changing lesions includes: successive data acquisitions according to different acquisition methods, so that, at each moment of acquisition, the user forms a set of data obtained according to respective acquisition methods; storage of the acquired data in a database; and displaying the data by selecting and displaying the selected data on a display screen. During displaying an item of data, the user inserts into an image being displayed at least one matching data item extracted from the database. | 11-11-2010 |
| 20100216757 | Sprayable compositions comprising pharmaceutical active agents, volatile silicones and a non-volatile oily phase - A process for improving the penetration of at least one pharmaceutical active agent into the skin, including formulating at least one volatile silicone, a non-volatile oily phase and a pharmaceutically acceptable alcoholic vehicle herewith, and spraying the formulation onto the skin of an individual in need of such treatment. | 08-26-2010 |
| 20090069279 | INVERT EMULSIONS CONTAINING DHEA - Stable, recrystallization-resistant invert emulsions, suited, e.g., for preventing/treating the signs of chronological or actinic skin aging and for preventing/treating atrophy of the skin or mucous membranes, comprise a cosmetically/therapeutically effective amount of DHEA and/or chemical and/or biological precursor or derivative thereof, such invert emulsions also comprising a glycolic or hydroglycolic dispersed hydrophilic phase, a lipophilic continuous phase and an emulsifier having an HLB ranging from 2 to 7. | 03-12-2009 |
| 20080293817 | ADMINISTRATION OF 6-[3-(1-ADAMANTYL)-4-METHOXYPHENYL]-2-NAPHTHOIC ACID FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS - Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions. | 11-27-2008 |
| 20080221189 | Use of Metronidazole For Preparing a Pharmaceutical Composition For Treating Pathologies Related to the B-Type Receptor of Interleukin 8 and/or to a Pacap Type 1 Receptor - The invention relates to use of metronidazole for the preparation of a pharmaceutical composition for treating pathologies involving at least one receptor chosen from the group comprising the IL-8RB receptor and the PAC-1 receptor. | 09-11-2008 |
